REGISTER NOW

Current Studies

A Study to Evaluate the Efficacy and Safety of SAGE-217 in Participants With Severe Postpartum Depression (PPD)

• For participants ages 18 to 45 experiencing Postpartum Depression.
• Gave birth within the last 6 months.
• Depression symptoms began at some point between the third trimester and 4 weeks after delivery.
• Willing to consider alternatives to breastfeeding while taking study medication (3 weeks).

Efficacy and Safety of Vibrant Capsule vs. Placebo for the Treatment of Chronic Idiopathic Constipation (Vibrant)

• For participants ages 22 and older
• On average have between 1 and 3 spontaneous (with out laxative) bowel movements a week.

A Phase 3 Study To Evaluate The Efficacy And Safety Of TNX-102 SL In Patients With Fibromyalgia (RALLY)

• For participants ages 18 to 65 experiencing fibromyalgia.
• Participants whose primary pain condition is fibromyalgia
• Willing to discuss stopping certain medications during the trial.

A Study to Test the Effectiveness and Safety of Fremanezumab on Patients With Fibromyalgia

• For participants ages 18 to 75 experiencing fibromyalgia.
• Participants whose primary pain condition is fibromyalgia
• Willing to discuss stopping certain medications during the trial.

ATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease (LIFT-AD)

• For participants ages 55 to 85 with Mild to Moderate Alzheimer's Dementia
• Reliable and capable support person/caregiver

A Phase 2a Combined Open-Label and Double-Blind, Placebo-Controlled Crossover Study Assessing the Effectiveness, Safety, and Tolerability of Oral Fasudil in Subjects with Dementia and Wandering Behaviors of Elopement and/or Getting Lost.

• For participants ages 50 to 90 with dementia of any kind
• Participant has wandering behaviors or gets lost.  Examples might include trouble finding a familiar location, trying to leave, pacing, or entering areas that are off-limits.
• Reliable and capable support person/caregiver